Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa

NCT05355805 is registered in ClinicalTrials.gov with ACELYRIN Inc. as lead sponsor.

NCT NCT05355805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05355805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa
Lead sponsor
ACELYRIN Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2022
Completion date
February 21, 2024
Enrollment
205 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa